CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: April 16, 2012
Result type: Reports
Project Number: SR0275-000
Product Line: Reimbursement Review

Generic Name: Fampridine

Brand Name: Fampyra

Manufacturer: Biogen Idec Canada Inc.

Therapeutic Area: Multiple sclerosis, improve walking disability

Indications: Multiple Sclerosis, improve walking disability

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: November 28, 2012

Recommendation Type: Do not list